- Category
- Medium (2024-25)
- Udyam number
- UDYAM-AP-10-0009655

About Actis Generics Private Limited
Data last updated:
Actis Generics Private Limited is a private limited company based in Vijayawada, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 03 May 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24230AP2012PTC080702. Its GSTIN is 37AAKCA5168N1Z1 (Andhra Pradesh).
The company has an authorised share capital of ₹7.55 Cr and a paid-up capital of ₹7.45 Cr. It is led by directors including Madhusudhana Reddy Bommareddy (Managing Director) and Venkatram Reddy Pulagam.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 39 – 8 – 19 B.S.Reddy Street Labbipet, Vijayawada, Andhra Pradesh, India – 520010.
As per the financials filed for FY 2024, the company reported a revenue of ₹70.08 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹6.54 Cr (net margin 9.3%) and EBITDA of ₹14.59 Cr (EBITDA margin 20.8%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 27% over five years.
The company has about 142 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹32.26 Cr and satisfied charges of ₹38.88 Cr on record. Court records list 7 cases involving the company, including 1 filed by the company and 6 filed against it; 3 cases are pending. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹7.2 Cr; the latest was in December 2014. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is S R Laboratories Private Limited with revenue of ₹72.1 Cr.
Actis Generics Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0009655). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website actispharma.com.
Company details
Recognitions & Rankings of Actis Generics
Contact details
Actis Generics Private Limited's registered office is in Vijayawada, Andhra Pradesh. Its website is actispharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address39 – 8 – 19 B.S.Reddy Street Labbipet, Vijayawada, Andhra Pradesh, India – 520010
- IndustryPharma, API Manufacturers
To see the full contact details of Actis Generics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Actis Generics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Actis Generics Private Limited, buy the company report.
Financials of Actis Generics Private Limited
FY 2024 filings availableActis Generics Private Limited reported revenue of ₹70.08 Cr (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 7% growth in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.59 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.54 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.8% | ||||
| Net Profit Margin | 9.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Actis Generics Private Limited, buy the company report.
Board of directors of Actis Generics Private Limited
Actis Generics has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkatram Reddy Pulagam Also directs: Reactis Pharmaceuticals Private Limited | Director | 03 May 2012 | 14 Years 6 Months | Current |
| Veera Venkata Siva Kumar Reddy Bommareddy Also directs: Reactis Pharmaceuticals Private Limited | Director | 03 May 2012 | 14 Years 6 Months | Current |
| Madhusudhana Reddy Bommareddy Also directs: Reactis Pharmaceuticals Private Limited, BSR Capital Limited | Managing Director | 03 May 2012 | 14 Years 6 Months | Current |
Peer comparison
Actis Generics Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| S R Laboratories Private Limited | ₹72.1 Cr (FY 2025) | 22.0% | Telangana, India | |||
| Pellets Pharma Limited | ₹72.09 Cr (FY 2024) | 2.0% | Hyderabad, Telangana, India | |||
| Chemcrux Enterprises Limited | ₹71.5 Cr (FY 2025) | -10.0% | Vadodara, Gujarat, India | |||
| Nico Orgo Marketing Private Limited | ₹70.53 Cr (FY 2024) | -50.0% | Kheda, Gujarat, India | |||
| Actis Generics Private Limitedthis company | ₹70.08 Cr (FY 2024) | ₹6.54 Cr | 9.3% | 7.0% | 142 | Vijayawada, Andhra Pradesh, India |
| Vibrant Pharmachem Private Limited | ₹69.73 Cr (FY 2024) | -10.0% | Raichur, Karnataka, India | |||
| Sunlight Active Drug Ingredients Private Limited | ₹69.28 Cr (FY 2025) | -2.0% | Hyderabad, Telangana, India | |||
| Amgis Lifescience Limited | ₹68.51 Cr (FY 2024) | 13.0% | Vapi, Gujarat, India | |||
| Sanmar Speciality Chemicals Limited | ₹68.48 Cr (FY 2018) | 11.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Actis Generics Private Limited, buy the company report.
Auditor
Actis Generics Private Limited is audited by BVS PRAKASH &CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BVS PRAKASH &CO | FY 2023 | 002727S |
Shareholding
The shareholding of Actis Generics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Actis Generics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Sep 2023 | 100821960 | Others | ₹20 Lakh | Open | |
| 17 Jun 2022 | 100590455 | Hdfc Bank Limited | ₹28.53 Lakh | Open | |
| 27 Jan 2022 | 100563264 | Others | ₹1.77 Cr | Open | |
| 18 Mar 2021 | 100464062 | Others | ₹30 Cr | Open | |
| 22 Feb 2019 | 100246273 | Others | ₹14.61 Cr | Satisfied |
To see the full charge records of Actis Generics Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Actis Generics Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹7.2 Cr; the latest was in December 2014.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2014 | Funding round | ₹4.45 Cr | Investors: 4 individuals |
| Apr 2013 | Funding round | ₹2.75 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Actis Generics Private Limited has 7 court cases on record: 1 filed by Actis Generics, 6 filed against it. 3 cases are pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 2 |
| High courts | 2 | 1 | 0 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1901-Energy Laws - Electricity, Petroleum, Oil and Natural Gas : Energy laws - Electricity, Petroleum, Oil and Natural Gas) | Filed against the company by The State of Andhra Pradesh | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd and 2 others | Disposed |
| District court, Visakapatnam, Andhra Pradesh | Civil suit | Filed against the company by an individual | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed against the company by Ap State Rep by the Inspector of Factories Visakhapatnam-Ii Factories Department, Govt. of A.P | Pending |
| District court, Visakapatnam, Andhra Pradesh | Court case (MVOP) | Filed against the company by individuals | Disposed |
To see the full case history of Actis Generics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Actis Generics Private Limited was last rated by Care on 07 Mar 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 07 Mar 2022 |
To see the full credit ratings and regulatory alerts of Actis Generics Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Actis Generics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Actis Generics Private Limited has a workforce of 142 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 142 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Actis Generics Private Limited, buy the company report.
GST
Actis Generics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAKCA5168N1Z1 | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Actis Generics Private Limited, buy the company report.
Recent activity
Actis Generics Private Limited has 5 board changes on record since 2012: 3 appointments and 2 cessations. The latest: Ramprasad Reddy Bommareddy ceased to be Director on 01 Feb 2025.
9 earlier events are in the company report.
Frequently asked questions
Actis Generics is an active private limited company based in Vijayawada, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 03 May 2012 (14+ years old) and is registered under CIN U24230AP2012PTC080702.
Actis Generics has 3 current directors:
- Madhusudhana Reddy Bommareddy - Managing Director
- Venkatram Reddy Pulagam - Director
- Veera Venkata Siva Kumar Reddy Bommareddy - Director
The latest financial statements of Actis Generics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Actis Generics is 37AAKCA5168N1Z1, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Actis Generics is U24230AP2012PTC080702. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Actis Generics has 7 court cases on record: 1 filed by the company and 6 filed against it. 3 are pending. Most are in the district courts.
Actis Generics was incorporated on 03 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Vijayawada.
Actis Generics has 2 deals on record (2 funding rounds), with disclosed funding of ₹7.2 Cr; the latest was in December 2014.
The peers of Actis Generics by revenue are S R Laboratories Private Limited, Pellets Pharma Limited, Chemcrux Enterprises Limited, Nico Orgo Marketing Private Limited, Vibrant Pharmachem Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ramprasad Reddy Bommareddy ceased to be Director on 01 Feb 2025. Usharani Bommareddy ceased to be Director on 01 Feb 2025. Madhusudhana Reddy Bommareddy was appointed as Managing Director on 03 May 2012. Actis Generics has 5 board changes on record in total.
Yes, Actis Generics is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-10-0009655).

